Medopharm Ofloxacin Export Data — India (DGFT 2022–2026)

Name: Medopharm Ofloxacin Export Records India — #8 Exporter, 62 Shipments, $3.1M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Ofloxacin

India Pharmaceutical Trade Intelligence

$295.2M1,094 Suppliers180 CountriesHS 30049099

ExportsIndia → UNITED STATES39.2%India → VIETNAM6.8%

ImportsMALTA → India$59.6M CHINA → India$17.1M

#1 Buyer: DR REDDYS

Medopharm — Ofloxacin Exporter #8 | $3.1M Trade Value | TransData Nexus | TransData Nexus

Medopharm — Ofloxacin Exporter Profile

Indian Pharmaceutical Exporter · #8 for Ofloxacin · $3.1M export value · DGFT Verified

Medopharm is the #8 Indian exporter of Ofloxacin with $3.1M in export value and 62 verified shipments. Medopharm holds a 1.0% market share in Ofloxacin exports across 15 countries. The company exports 21 pharmaceutical products worth $50.2M across 10 therapeutic categories.

Medopharm — Ofloxacin Export Profile: Buyers & Destinations

Medopharm Ofloxacin export treemap — buyers and destination countries | TransData Nexus

Where Does Medopharm Export Ofloxacin?

Country	Value	Shipments	Share
UNITED ARAB EMIRATES	$543.5K	33	26.0%
NETHERLANDS	$473.1K	19	22.6%
GERMANY	$344.7K	14	16.5%
TANZANIA	$207.3K	7	9.9%
AFGHANISTAN	$110.5K	4

Who Are the Top Buyers of Ofloxacin from Medopharm?

Buyer	Country	Value	Orders
IMRES	NETHERLANDS	$209.2K	9
PLANET PHARMACEUTICALS LIMITED	TANZANIA	$169.6K	5
M/S. DB SCHENKER LOGISTICS NETHERLA	NETHERLANDS	$130.1K	4
M/S. IDA TRADING MEA C/O KUEHNE + N	UNITED ARAB EMIRATES	$121.9K	4
IDA TRADING MEAC/OKUEHNE+NAGEL LLC.	UNITED ARAB EMIRATES	$120.1K	7
M/S. UNITED NATIONS CHILDREN'S FUND	AFGHANISTAN	$110.5K	4
PHILCO PHARMA E K.	GERMANY	$106.7K	4
PHILCO PHARMA E K	GERMANY	$93.7K	4
M/S. PHILCO PHARMA E.K	GERMANY	$90.0K	4
IDA TRADING MEA C/OKUEHNE+NAGEL LLC	UNITED ARAB EMIRATES	$74.6K	6

Medopharm supplies Ofloxacin to 48 buyers globally. The largest buyer is IMRES (NETHERLANDS), followed by PLANET PHARMACEUTICALS LIMITED (TANZANIA) and M/S. DB SCHENKER LOGISTICS NETHERLA (NETHERLANDS). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Ofloxacin Formulations Does Medopharm Export?

Product Description / Formulation	Value	Shipments
CIPROFLOXACIN TABLETS USP 500MG (5000 X	$138.1K	5
CIPROFLOXACIN TABLETS USP 250MG(12000 X	$117.4K	3
CIPROFLOXACIN TABLETS USP 500MG (1500 X	$112.0K	3
CIPROFLOXACIN TABLETS USP 500MG (10000 X10 X 10) - BOX	$81.6K	4
PHILCO CIPRO 500MG (CIPROFLOXACIN TABLET	$80.4K	3
PHILCO-CIPRO 500 (CIPROFLOXACIN TABLETSUSP 500MG) (10000 X 12 X 10) - BOX	$54.0K	2
PHILCO-CIPRO 500 (CIPROFLOXACIN TABLETSUSP 500MG ) (50000 X 2 X 10) - BOX	$53.6K	2
CIPROFLOXACIN TABLETS USP 250MG (100000	$52.1K	2
CIPROFLOXACIN TABLETS USP 250MG (258850	$50.0K	1
CIPROFLOXACIN TABLETS USP 500MG 49694 X10 X 10 - BOX	$50.0K	1

Medopharm exports 85 distinct Ofloxacin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is CIPROFLOXACIN TABLETS USP 500MG (5000 X with 5 shipments worth $138.1K.

How Does Medopharm Compare to Nearest Ofloxacin Exporters?

Exporters ranked immediately above and below #8 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	DR.REDDY'S LABORATORIES LTD	$3.7M	74	2	$50.0K
15	ZYDUS LIFESCIENCES LIMITED	$3.4M	96	14	$35.6K
8	MEDOPHARM ★	$3.1M	62	15	$50.0K
13	MEDCELL PHARMA	$1.9M	38	4	$50.0K
2	DR REDDYS LABORATORIES LIMITED	$1.3M	26	1	$50.0K

Medopharm ranks #8 among 1094 Indian Ofloxacin exporters. Average shipment value of $50.0K compared to the market average of $65.6K. The closest competitors by value are DR.REDDY'S LABORATORIES LTD and ZYDUS LIFESCIENCES LIMITED.

Which Indian Ports Ship Ofloxacin Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	1,841	12.3%
DELHI AIR CARGO ACC (INDEL4)	1,504	10.0%
SAHAR AIR	1,292	8.6%
NHAVA SHEVA SEA (INNSA1)	1,262	8.4%
DELHI AIR	894	6.0%
Bombay Air	655	4.4%
JNPT/ NHAVA SHEVA SEA	645	4.3%
Delhi Air	361	2.4%

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Ofloxacin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Medopharm matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 116 individual customs records matching Medopharm exporting Ofloxacin, covering 85 formulations to 23 countries via 48 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 180+ countries, 3,093+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Ofloxacin

Ofloxacin

Medopharm — Ofloxacin Exporter Profile

Medopharm — Ofloxacin Export Profile: Buyers & Destinations

Where Does Medopharm Export Ofloxacin?

Who Are the Top Buyers of Ofloxacin from Medopharm?

What Is India's Total Ofloxacin Export Value and How Much Does Medopharm Contribute?

What Is the Average Shipment Value for Medopharm's Ofloxacin Exports?

How Does Medopharm Compare to Other Indian Ofloxacin Exporters?

What Ofloxacin Formulations Does Medopharm Export?

Regulatory Requirements: Exporting Ofloxacin to Key Markets

Germany — BfArM/EMA

How Does Medopharm Compare to Nearest Ofloxacin Exporters?

Which Indian Ports Ship Ofloxacin Exports?

What Other Advanced Antibiotics Products Does Medopharm Export?

Geopolitical & Trade Policy Impact on Medopharm's Ofloxacin Exports

Medopharm — Regulatory Compliance & Quality Standards

About Medopharm

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Ofloxacin Export Data from Medopharm

Ofloxacin Stats

Company Overview

Top Products by Medopharm

Related Analysis

Need Detailed Export Data?

Data Source